Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression: a pragmatic, open-label, parallel-group, randomised controlled superiority trial in the UK (vol 12, pg 276, 2025)
Cleare AJ., Kerr-Gaffney J., Goldsmith K., Zenasni Z., Yaziji N., Jin H., Colasanti A., Geddes JR., Kessler D., McAllister-Williams RH., Young AH., Barrera A., Marwood L., Taylor RW., Tee H.